Grover's-like disease in the setting of bone marrow transplantation and autologous peripheral blood stem cell infusion

American Journal of Dermatopathology

Volumn 20, Issue 2, 1998, Pages 179-184

  Harvell, Jeff D ^a   Hashem, Christine ^a   Williford, Phillip L ^a   White, Wain L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Autologous peripheral blood stem cell infusion; Bone marrow transplant; Chemotherapy; Etoposide; Grover's disease; Starburst cells; Transient acantholytic dyskeratosis; VP 16

Indexed keywords

BUSULFAN; CARBOPLATIN; CD34 ANTIGEN; CHLORHEXIDINE GLUCONATE; CYCLOPHOSPHAMIDE; ETOPOSIDE; TRIAMCINOLONE ACETONIDE;

ACANTHOLYTIC DYSKERATOSIS; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KERATINOCYTE; LEUKEMIA; LYMPHOMA; MALE; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PUNCH BIOPSY; RASH; STEM CELL TRANSPLANTATION; TOPICAL DRUG ADMINISTRATION; WHOLE BODY RADIATION;

ACANTHOLYSIS; ADULT; BONE MARROW TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY; ETOPOSIDE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS;

EID: 0031979956     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199804000-00014     Document Type: Article

References (17)

1. Held JL, Bank D, Grossman ME. Grover's disease provoked by ionizing radiation. J Am Acad Dermatol 1988;19:137-8.
2. Horn TD, Groleau GE. Transient acantholytic dermatosis in immunocompromised febrile patients with cancer. Arch Dermatol 1987;123:238-40.
3. Guana AL, Cohen PR. Transient acantholytic dermatosis in oncology patients. J Clin Oncol 1994;12:1703-9.
4. Manteaux AM, Rapini RP. Transient acantholytic dermatosis in patients with cancer. Cutis 1990;46:488-90.
5. Mahler SJ, DeVillez RL, Pulitzer DR. Transient acantholytic dermatosis induced by recombinant human interleuken 4. J Am Acad Dermatol 1993;29:206-9.
6. Liss WA, Norris AL. Zosteriform transient acantholytic dermatosis. J Am Acad Dermatol 1993;29:797-8.
7. Rockley PF, Bergfeld WF, Tomecki KJ, Brydon JK. Myelodysplastic syndrome and transient acantholytic dermatosis. Cleve Clin J Med 1990;57:575-7.
8. Yaffee HS. Possible dysglobulinemia and Grover's disease (letter). Arch Dermatol 1981;117:3.
9. Zelickson BD, Tefferi A, Gertz MA, Banks PM, Pittelkow MR. Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathy. Acta Derm Venereol (Stockh) 1989;69:445-8.
10. Beutner EH, Nisengard RJ, Kumar V. Defined immunofluorescence: basic concepts and their application to clinical immunodermatology. In: Beutner EH, Chorzelski TP, Bean SF, eds. Immunopathy of the skin. 2nd ed. New York: John Wiley and Sons, 1979:29-75.
11. Hu CH, Michel B, Farber EM. Transient acantholytic dermatosis (Grover's disease): a skin disorder related to heal and sweating. Arch Dermatol 1985;121:1439-41.
12. Horn TD. Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 1994;21:385-92.
13. Horn TD. Antineoplaslic chemotherapy, sweat, and the skin. Arch Dermatol 1997;13:905-6.
14. Horn TD, Beveridge RA, Egorin MJ, Abeloff MJ, Hood AF. Observations and proposed mechanisms of N, N, N-triethylenethiophosphoramide (Thio-TEPA)-induced hyperpigmentation. Arch Dermatol 1989;125:524-7.
15. Valks R, Fraga J, Porras-Luque J, Figuera A, Garcia-Diéz A, Fernández-Herrera J. Chemotherapy-induced eccrine squamous syringometaplasia: a distinctive eruption in patients receiving hematopoictic progenitor cells. Arch Dermatol 1997;133:873-8.
16. Yokel BK, Friedman J, Farmer ER, Hood AF. Cutaneous pathology following etoposide therapy. J Cutan Pathol 1987;4:326-30.
17. Hymes SR, Simonton SC, Farmer ER, Beschorner WB, Tutschka PJ, Santos GW. Cutaneous busulfan effect in patients receiving bone marrow transplantation. J Cutan Pathol 1985;12:125-9.